Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

ASPN

Live52w high -42.7%

Core line items from ASPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: ASPEN AEROGELS, INC.·Source: SEC EDGAR companyfacts

Metric	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$37.88M	$271.10M	$229.76M	$156.75M
Operating Income	$-20.83M	$-378.23M	$-307.84M	$-304.50M
Net Income	$-23.69M	$-389.55M	$-316.64M	$-9.06M
EPS (Diluted)	$-0.29	$-4.73	$-3.85	$-3.78
Total Assets	$410.48M	$406.68M	$491.39M	$525.13M
Total Liabilities	$196.98M	$171.16M	$185.66M	$216.36M
Cash & Equivalents	$173.87M	$156.86M	$150.72M	$167.62M
Free Cash Flow OCF − CapEx	$32.78M	$-4.58M	$-18.25M	$-24.18M
Shares Outstanding	82.83M	82.71M	82.56M	82.25M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from ASPN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w high -42.7%

Entity: ASPEN AEROGELS, INC.·Source: SEC EDGAR companyfacts

Metric	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$37.88M	$271.10M	$229.76M	$156.75M
Operating Income	$-20.83M	$-378.23M	$-307.84M	$-304.50M
Net Income	$-23.69M	$-389.55M	$-316.64M	$-9.06M
EPS (Diluted)	$-0.29	$-4.73	$-3.85	$-3.78
Total Assets	$410.48M	$406.68M	$491.39M	$525.13M
Total Liabilities	$196.98M	$171.16M	$185.66M	$216.36M
Cash & Equivalents	$173.87M	$156.86M	$150.72M	$167.62M
Free Cash Flow OCF − CapEx	$32.78M	$-4.58M	$-18.25M	$-24.18M
Shares Outstanding	82.83M	82.71M	82.56M	82.25M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.